A Study to Evaluate Efficacy and Safety of JTZ-951 Compared to Darbepoetin Alfa in Korean Renal Anemia Patients Receiving Hemodialysis.

NCT04027517 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

172

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia of Chronic Kidney Disease

Interventions

DRUG: JTZ-951
DRUG: Darbepoetin Alfa

Sponsor

JW Pharmaceutical